Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0B6CC
|
||||
| Former ID |
DAP001143
|
||||
| Drug Name |
Trimethaphan
|
||||
| Synonyms |
Thimethaphan; Trimetaphan; Trimetaphanum; Arfonad (TN); Thieno(1',2':1,2)thieno(3,4-d)imidazol-5-ium, decahydro-2-oxo-1,3-bis(phenylmethyl)-(VAN); 1,3-dibenzyl-2-oxodecahydrothieno[1',2':1,2]thieno[3,4-d]imidazol-5-ium
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Hypertensive emergencies; Aneurysm [ICD9: 401-405; ICD10:I10, I72] | Approved | [1], [2] | ||
| Therapeutic Class |
Antihypertensive Agents
|
||||
| Company |
Hoffmann La Roche Inc
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C22H25N2OS+
|
||||
| Canonical SMILES |
C1CC2C3C(C[S+]2C1)N(C(=O)N3CC4=CC=CC=C4)CC5=CC=CC=C5
|
||||
| InChI |
1S/C22H25N2OS/c25-22-23(14-17-8-3-1-4-9-17)19-16-26-13-7-12-20(26)21(19)24(22)15-18-10-5-2-6-11-18/h1-6,8-11,19-21H,7,12-16H2/q+1
|
||||
| InChIKey |
CHQOEHPMXSHGCL-UHFFFAOYSA-N
|
||||
| CAS Number |
CAS 7187-66-8
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| SuperDrug ATC ID |
C02BA01
|
||||
| SuperDrug CAS ID |
cas=007187668
|
||||
| Target and Pathway | |||||
| Target(s) | Neuronal acetylcholine receptor protein, alpha-4 chain | Target Info | Antagonist | [3] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
| Cholinergic synapse | |||||
| Nicotine addiction | |||||
| PANTHER Pathway | Nicotinic acetylcholine receptor signaling pathway | ||||
| Nicotine pharmacodynamics pathway | |||||
| Reactome | Highly sodium permeable acetylcholine nicotinic receptors | ||||
| Highly calcium permeable postsynaptic nicotinic acetylcholine receptors | |||||
| Highly calcium permeable nicotinic acetylcholine receptors | |||||
| WikiPathways | SIDS Susceptibility Pathways | ||||
| Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell | |||||
| Nicotine Activity on Dopaminergic Neurons | |||||
| References | |||||
| REF 1 | Drug information of Trimethaphan, 2008. eduDrugs. | ||||
| REF 2 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | ||||
| REF 3 | Mechanism of long-lasting block of ganglion nicotinic receptors by mono-ammonium compounds with long aliphatic chain. J Auton Nerv Syst. 1994 Aug;48(3):231-40. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.